These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7824511

  • 1. p53 mutations and MDM-2 amplification in renal cell cancers.
    Imai Y, Strohmeyer TG, Fleischhacker M, Slamon DJ, Koeffler HP.
    Mod Pathol; 1994 Sep; 7(7):766-70. PubMed ID: 7824511
    [Abstract] [Full Text] [Related]

  • 2. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.
    Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708
    [Abstract] [Full Text] [Related]

  • 3. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
    Habuchi T, Kinoshita H, Yamada H, Kakehi Y, Ogawa O, Wu WJ, Takahashi R, Sugiyama T, Yoshida O.
    J Natl Cancer Inst; 1994 Sep 07; 86(17):1331-5. PubMed ID: 8064891
    [Abstract] [Full Text] [Related]

  • 4. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H, Matthay K, Schmitt B, Bauknecht T, Kiechle-Schwarz M, Göppinger A, Pfleiderer A.
    Cancer; 1995 Jul 01; 76(1):57-66. PubMed ID: 8630877
    [Abstract] [Full Text] [Related]

  • 5. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
    Soslow RA, Altorki NK, Yang G, Xie D, Yang CS.
    Mod Pathol; 1999 Jun 01; 12(6):580-6. PubMed ID: 10392633
    [Abstract] [Full Text] [Related]

  • 6. p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters.
    Okita S, Tsutsumi M, Onji M, Konishi Y.
    Mol Carcinog; 1995 Aug 01; 13(4):266-71. PubMed ID: 7646765
    [Abstract] [Full Text] [Related]

  • 7. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I, Tanaka H, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K.
    Clin Cancer Res; 1995 Jul 01; 1(7):769-73. PubMed ID: 9816044
    [Abstract] [Full Text] [Related]

  • 8. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T.
    Cancer Res; 1992 Oct 01; 52(19):5323-8. PubMed ID: 1327506
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of the p53 and MDM-2 gene in acute myeloid leukemia.
    Seliger B, Papadileris S, Vogel D, Hess G, Brendel C, Störkel S, Ortel J, Kolbe K, Huber C, Huhn D, Neubauer A.
    Eur J Haematol; 1996 Sep 01; 57(3):230-40. PubMed ID: 8898928
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 13. Mutations of the p53 gene are not detectable in human testicular tumors.
    Fleischhacker M, Strohmeyer T, Imai Y, Slamon DJ, Koeffler HP.
    Mod Pathol; 1994 May 15; 7(4):435-9. PubMed ID: 8066072
    [Abstract] [Full Text] [Related]

  • 14. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
    Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP.
    Cancer Res; 1993 Jun 15; 53(12):2736-9. PubMed ID: 8504413
    [Abstract] [Full Text] [Related]

  • 15. The p53 and mdm-2 genes in human testicular germ-cell tumors.
    Riou G, Barrois M, Prost S, Terrier MJ, Theodore C, Levine AJ.
    Mol Carcinog; 1995 Mar 15; 12(3):124-31. PubMed ID: 7893365
    [Abstract] [Full Text] [Related]

  • 16. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
    Contractor H, Zariwala M, Bugert P, Zeisler J, Kovacs G.
    J Pathol; 1997 Feb 15; 181(2):136-9. PubMed ID: 9120715
    [Abstract] [Full Text] [Related]

  • 17. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.
    Patterson H, Gill S, Fisher C, Law MG, Jayatilake H, Fletcher CD, Thomas M, Grimer R, Gusterson BA, Cooper CS.
    Br J Cancer; 1994 Jun 15; 69(6):1052-8. PubMed ID: 8198970
    [Abstract] [Full Text] [Related]

  • 18. Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.
    Ittmann M, Wieczorek R, Heller P, Dave A, Provet J, Krolewski J.
    Am J Pathol; 1994 Aug 15; 145(2):287-93. PubMed ID: 8053489
    [Abstract] [Full Text] [Related]

  • 19. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
    Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ.
    Cancer Res; 1994 Feb 01; 54(3):794-9. PubMed ID: 8306343
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression.
    Poremba C, Yandell DW, Metze D, Kamanabrou D, Böcker W, Dockhorn-Dworniczak B.
    Oncol Res; 1995 Feb 01; 7(7-8):331-9. PubMed ID: 8747596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.